Anagha Vaze

Dr. Anagha Vaze is a Clinical Lecturer affiliated with the University of Sydney's Faculty of Medicine and Health (FMH) and the Save Sight Institute. Her expertise lies in ophthalmology, with a focus on retinal disorders, diabetic eye diseases, and clinical research. She has contributed to studies on VEGF inhibitors, corticosteroid delivery platforms for macular edema, and the application of genomics in retinal diagnostics.

• Research Interests:
  • Retinal degeneration and vascular abnormalities
  • Management strategies for diabetic retinopathy and macular telangiectasia
  • Clinical outcomes of anti-VEGF therapies
  • Infectious diseases in immunocompromised patients (e.g., heart transplant recipients)

Her publications (2014–2022) emphasize observational studies, drug delivery innovations, and case reports on rare infections. Key contributions include assessing treatment discontinuation protocols for neovascular AMD and exploring photobiomodulation for diabetic macular edema.

While no scientific awards or grants are explicitly listed, her work reflects active engagement in clinical research and patient care. She is part of the Save Sight Institute, a prominent research center within the FMH, focusing on vision science and ophthalmic advancements.